Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Lung cancer

Results: 1-25/845

Authors: Sutedja, TG Venmans, BJ Smit, EF Postmus, PE
Citation: Tg. Sutedja et al., Fluorescence bronchoscopy for early detection of lung cancer - A clinical perspective, LUNG CANC, 34(2), 2001, pp. 157-168

Authors: Vansteenkiste, JF De Belie, B Deneffe, GJ Demedts, MG De Leyn, PR Van Raemdonck, DE Lerut, TE
Citation: Jf. Vansteenkiste et al., Practical approach to patients presenting with multiple synchronous suspect lung lesions - A reflection on the current TNM classification based on 54cases with complete follow-up, LUNG CANC, 34(2), 2001, pp. 169-175

Authors: Lewis, SJ Cherry, NM Niven, RM Barber, PV Povey, AC
Citation: Sj. Lewis et al., Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population, LUNG CANC, 34(2), 2001, pp. 177-183

Authors: Jimenez-Orozco, FA Lopez-Gonzalez, JS Nieto-Rodriguez, A Velasco-Velaquez, MA Molina-Guarneros, JA Mendoza-Patino, N Garcia-Mondragon, MJ Elizalde-Galvan, P Leon-Cedeno, F Mandoki, JJ
Citation: Fa. Jimenez-orozco et al., Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin, LUNG CANC, 34(2), 2001, pp. 185-194

Authors: Suzuki, Y Yanagawa, H Nishioka, Y Nishimura, N Takeuchi, E Sone, S
Citation: Y. Suzuki et al., Efficient generation of dendritic cells from alveolar and pleural macrophages as well as blood monocytes in patients with lung cancer, LUNG CANC, 34(2), 2001, pp. 195-205

Authors: Jin, ML Inoue, S Umemura, T Moriya, J Arakawa, M Nagashima, K Kato, H
Citation: Ml. Jin et al., Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II, LUNG CANC, 34(2), 2001, pp. 207-218

Authors: Hara, H Yamashita, K Shinada, J Yoshimura, H Kameya, T
Citation: H. Hara et al., Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 219-226

Authors: Potti, A Ganti, AK Koch, M Mehdi, SA Levitt, R
Citation: A. Potti et al., Identification of HER-2/neu overexpression and the clinical course of lungcarcinoma in non-smokers with chronic lymphocytic leukemia, LUNG CANC, 34(2), 2001, pp. 227-232

Authors: Ushijima, C Tsukamoto, S Yamazaki, K Yoshino, I Sugio, K Sugimachi, K
Citation: C. Ushijima et al., High vascularity in the peripheral region of non-small cell lung cancer tissue is associated with tumor progression, LUNG CANC, 34(2), 2001, pp. 233-241

Authors: Bozcuk, H Martin, C
Citation: H. Bozcuk et C. Martin, Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre, LUNG CANC, 34(2), 2001, pp. 243-252

Authors: Anacak, Y Mogulkoc, N Ozkok, S Goksel, T Haydaroglu, A Bayindir, U
Citation: Y. Anacak et al., High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 253-259

Authors: Novello, S Galli, L Antonuzzo, A Crino, L Pozzi, E Selvaggi, G Ricci, S Marrocolo, F Darwish, S Sorbolini, S Tonato, M Scagliotti, GV
Citation: S. Novello et al., Phase II study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 261-269

Authors: Clark, JI Kancharla, K Qamar, R Fisher, S Hantel, A Panganiban, J Millbrandt, L Albain, KS
Citation: Ji. Clark et al., Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 271-277

Authors: Ceresoli, GL Locati, LD Ferreri, AJM Cozzarini, C Passoni, P Melloni, G Zannini, P Bolognesi, A Villa, E
Citation: Gl. Ceresoli et al., Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma, LUNG CANC, 34(2), 2001, pp. 279-287

Authors: Kosty, MP Herndon, JE Vogelzang, NJ Kindler, HL Green, MR
Citation: Mp. Kosty et al., High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study - Cancer and Leukemia Group B 9631, LUNG CANC, 34(2), 2001, pp. 289-295

Authors: Langer, CJ
Citation: Cj. Langer, The role of UFT and the combination of UFT/leucovorin in non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 297-303

Authors: Montalar, J Morales, S Maestu, I Camps, C Vadell, C Garcia, R Yuste, AL Torregrosa, D Segura, A
Citation: J. Montalar et al., Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 305-311

Authors: Scarpati, MD Vicidomini, G Santini, M
Citation: Md. Scarpati et al., Gemcitabine and small cell lung cancer, LUNG CANC, 34(2), 2001, pp. 313-314

Authors: Jelic, S Mitrovic, L Radosavljevic, D Elezar, E Babovic, N Kovcin, V Tomasevic, Z Kovacevic, S Gavrilovic, D Radulovic, S
Citation: S. Jelic et al., Survival advantage for carboplatin substituting cisplatin in combination with vindesine and mitomycin C for stage IIIB and IV squamous-cell bronchogenic carcinoma: a randomized phase III study, LUNG CANC, 34(1), 2001, pp. 1-13

Authors: Berghmans, T Paesmans, M Sculier, JP
Citation: T. Berghmans et al., Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy?, LUNG CANC, 34(1), 2001, pp. 15-17

Authors: van Dijck, JAAM Festen, J de Kleijn, EMHA Kramer, GWPM Tjan-Heijnen, VCG Verbeek, ALM
Citation: Jaam. Van Dijck et al., Treatment and survival of patients with non-small cell lung cancer stage IIIA diagnosed in 1989-1994: a study in the region of the Comprehensive Cancer Centre East, The Netherlands, LUNG CANC, 34(1), 2001, pp. 19-27

Authors: Ichinose, Y Kato, H Koike, T Tsuchiya, R Fujisawa, T Shimizu, N Watanabe, Y Mitsudomi, T Yoshimura, M
Citation: Y. Ichinose et al., Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the JapanClinical Oncology Group to plan for clinical trials, LUNG CANC, 34(1), 2001, pp. 29-36

Authors: Alavanja, MCR Field, RW Sinha, R Brus, CP Shavers, VL Fisher, EL Curtain, J Lynch, CF
Citation: Mcr. Alavanja et al., Lung cancer risk and red meat consumption among Iowa women, LUNG CANC, 34(1), 2001, pp. 37-46

Authors: Sasaki, H Chen, LB Auclair, D Moriyama, S Kaji, M Fukai, I Kiriyama, M Yamakawa, Y Fujii, Y
Citation: H. Sasaki et al., Overexpression of Hrad17 gene in non-small cell lung cancers correlated with lymph node metastasis, LUNG CANC, 34(1), 2001, pp. 47-52

Authors: Sasaki, H Moriyama, S Yukiue, H Kobayashi, Y Nakashima, Y Kaji, M Fukai, I Kiriyama, M Yamakawa, Y Fujii, Y
Citation: H. Sasaki et al., Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer, LUNG CANC, 34(1), 2001, pp. 53-57
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>